Medication info

Albimus Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Cielpharm Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201906211 · Approved 2019.09.01

This product's status changed to Expired on 2024.09.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (including gastric and duodenal ulcers and gastritis); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer for some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Ingredients

Manufacturer
Cielpharm Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (including gastric and duodenal ulcers and gastritis); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used for various gastrointestinal diseases including gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered before anesthesia to prevent Mendelson's syndrome, treat ulcers that may occur after surgery, and help manage gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is effective for alleviating and treating the symptoms of these conditions.

How to take

Adult dose

Usually, take 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer for some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with poor kidney function. Additionally, it should not be administered to patients who have had an allergic reaction to this medication or its components, a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients on a restricted potassium diet. Patients with liver dysfunction, a history of drug hypersensitivity, the elderly, those with a history of renal impairment, and patients taking non-steroidal anti-inflammatory drugs should use this medication with caution. Particularly, it may mask symptoms of gastric cancer, so gastric ulcer patients or those over middle age with newly occurring dyspeptic symptoms should use it only after confirming the nature of the malignant condition. While taking this medication, allergy reactions, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and psychiatric symptoms may arise, so if any symptoms occur, immediate consultation with medical personnel is advised. Long-term use should be avoided, and it should be administered at the minimum effective dose while monitoring treatment progress. It is advisable to avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may interact with other drugs; thus, it is important to inform healthcare providers, especially if taking anticoagulants, antibiotics, or anticonvulsants, to ensure proper caution. Pregnant or breastfeeding women are advised not to use this medication, and its safety and efficacy have not been confirmed in children, so it is best not to administer it to them. In cases of overdose, appropriate treatment such as vomiting or gastric lavage may be necessary, and in severe cases, removal via hemodialysis may be required. Finally, this medication can reduce gastric acid secretion and promote bacterial proliferation in the stomach; long-term users should undergo ophthalmic examinations.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 64 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodepressive syndrome
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sense
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • hepatic myoclonus
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild polymorphic erythema
  • alopecia
  • glossitis
  • pruritus
  • blackening of the tongue
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer duration.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.